Search Results

Displaying Results 1-1 of 1 "'STRM'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

Dec 03, 2025, 08:00 ET STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

will act as lead for the project, bringing their novel MV platform and expertise in bone marrow-targeted in vivo delivery. As the Prime Awardee, STRM will collaborate with Ginkgo Bioworks (NYSE: DNA), the University of British Columbia (UBC), and Advanced Bioprocess Services (ABS) to develop in

More news about: STRM.BIO

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.